Enteral Nutrition Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025

Description

The global enteral nutrition market is experiencing significant growth, driven by the increasing geriatric population and the rising number of malnutrition cases receiving treatment. In 2024, the market size is estimated at USD 8.3 billion and is projected to reach USD 13.1 billion by 2032, advancing at a compound annual growth rate (CAGR) of 5.9% during the forecast period.

This growth is primarily attributed to the shift from parenteral to enteral nutrition, owing to its lower complication rates and costs. Enteral nutrition is increasingly preferred for long-term feeding, especially in elderly patients, enhancing clinical outcomes and reducing septic and non-septic complications.

Key Insights

The market is segmented into standard and disease-specific formulations. Standard formulations are widely used; however, disease-specific formulas are gaining traction due to their tailored nutritional content for conditions such as diabetes and renal disorders.

Enteral nutrition products are formulated with proteins, carbohydrates, multivitamins, antioxidants, amino acids, fibers, and minerals to meet the diverse nutritional needs of patients.

Hospital pharmacies dominate the distribution landscape, ensuring immediate availability for inpatients. Retail and online pharmacies are also significant channels, providing accessibility for outpatient and home-based care.

Products are available in powder and liquid forms, offering flexibility in administration based on patient needs and preferences.

While adults constitute the majority of enteral nutrition consumers, there is a notable segment for pediatric patients, addressing malnutrition and chronic conditions in children.

North America holds the largest market share, attributed to a well-established healthcare infrastructure and a significant number of product manufacturers. The Asia-Pacific region is anticipated to witness the fastest growth, with a CAGR of 7%, driven by an increase in chronic diseases, a growing elderly population, and advancements in healthcare facilities.

The surge in chronic diseases such as cancer, neurological disorders, and gastrointestinal conditions necessitates nutritional support, thereby propelling market growth. Additionally, the cost-effectiveness and reduced complication rates of enteral nutrition over parenteral methods contribute to its increased adoption.

Potential complications, such as infections and tube displacements, pose challenges to market growth. However, advancements in tube design and placement techniques are mitigating these risks.

The growing awareness of early enteral feeding benefits, such as improved patient outcomes and reduced hospital stays, presents opportunities for market expansion. Moreover, the development of innovative, disease-specific formulations caters to the personalized nutrition needs of patients, further driving market growth.

Product Code: 10657

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by nutrition type
- 1.4.3. Market size breakdown, by form
- 1.4.4. Market size breakdown, by patient type
- 1.4.5. Market size breakdown, by distribution channel
- 1.4.6. Market size breakdown, by region
- 1.4.7. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Product Type (2019-2030)
6.3. Market Revenue, by Nutrition Type (2019-2030)
6.4. Market Revenue, by Form (2019-2030)
6.5. Market Revenue, by Patient Type (2019-2030)
6.6. Market Revenue, by Distribution Channel (2019-2030)
6.7. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Product Type (2019-2030)
7.3. Market Revenue, by Nutrition Type (2019-2030)
7.4. Market Revenue, by Form (2019-2030)
7.5. Market Revenue, by Patient Type (2019-2030)
7.6. Market Revenue, by Distribution Channel (2019-2030)
7.7. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Product Type (2019-2030)
8.3. Market Revenue, by Nutrition Type (2019-2030)
8.4. Market Revenue, by Form (2019-2030)
8.5. Market Revenue, by Patient Type (2019-2030)
8.6. Market Revenue, by Distribution Channel (2019-2030)
8.7. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Product Type (2019-2030)
9.3. Market Revenue, by Nutrition Type (2019-2030)
9.4. Market Revenue, by Form (2019-2030)
9.5. Market Revenue, by Patient Type (2019-2030)
9.6. Market Revenue, by Distribution Channel (2019-2030)
9.7. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Product Type (2019-2030)
10.3. Market Revenue, by Nutrition Type (2019-2030)
10.4. Market Revenue, by Form (2019-2030)
10.5. Market Revenue, by Patient Type (2019-2030)
10.6. Market Revenue, by Distribution Channel (2019-2030)
10.7. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Product Type (2019-2030)
11.3. Market Revenue, by Nutrition Type (2019-2030)
11.4. Market Revenue, by Form (2019-2030)
11.5. Market Revenue, by Patient Type (2019-2030)
11.6. Market Revenue, by Distribution Channel (2019-2030)
11.7. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Product Type (2019-2030)
12.3. Market Revenue, by Nutrition Type (2019-2030)
12.4. Market Revenue, by Form (2019-2030)
12.5. Market Revenue, by Patient Type (2019-2030)
12.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Product Type (2019-2030)
13.3. Market Revenue, by Nutrition Type (2019-2030)
13.4. Market Revenue, by Form (2019-2030)
13.5. Market Revenue, by Patient Type (2019-2030)
13.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Product Type (2019-2030)
14.3. Market Revenue, by Nutrition Type (2019-2030)
14.4. Market Revenue, by Form (2019-2030)
14.5. Market Revenue, by Patient Type (2019-2030)
14.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Product Type (2019-2030)
15.3. Market Revenue, by Nutrition Type (2019-2030)
15.4. Market Revenue, by Form (2019-2030)
15.5. Market Revenue, by Patient Type (2019-2030)
15.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Product Type (2019-2030)
16.3. Market Revenue, by Nutrition Type (2019-2030)
16.4. Market Revenue, by Form (2019-2030)
16.5. Market Revenue, by Patient Type (2019-2030)
16.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Product Type (2019-2030)
17.3. Market Revenue, by Nutrition Type (2019-2030)
17.4. Market Revenue, by Form (2019-2030)
17.5. Market Revenue, by Patient Type (2019-2030)
17.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Product Type (2019-2030)
18.3. Market Revenue, by Nutrition Type (2019-2030)
18.4. Market Revenue, by Form (2019-2030)
18.5. Market Revenue, by Patient Type (2019-2030)
18.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Product Type (2019-2030)
19.3. Market Revenue, by Nutrition Type (2019-2030)
19.4. Market Revenue, by Form (2019-2030)
19.5. Market Revenue, by Patient Type (2019-2030)
19.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Product Type (2019-2030)
20.3. Market Revenue, by Nutrition Type (2019-2030)
20.4. Market Revenue, by Form (2019-2030)
20.5. Market Revenue, by Patient Type (2019-2030)
20.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Product Type (2019-2030)
21.3. Market Revenue, by Nutrition Type (2019-2030)
21.4. Market Revenue, by Form (2019-2030)
21.5. Market Revenue, by Patient Type (2019-2030)
21.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Product Type (2019-2030)
22.3. Market Revenue, by Nutrition Type (2019-2030)
22.4. Market Revenue, by Form (2019-2030)
22.5. Market Revenue, by Patient Type (2019-2030)
22.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Product Type (2019-2030)
23.3. Market Revenue, by Nutrition Type (2019-2030)
23.4. Market Revenue, by Form (2019-2030)
23.5. Market Revenue, by Patient Type (2019-2030)
23.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Product Type (2019-2030)
24.3. Market Revenue, by Nutrition Type (2019-2030)
24.4. Market Revenue, by Form (2019-2030)
24.5. Market Revenue, by Patient Type (2019-2030)
24.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Product Type (2019-2030)
25.3. Market Revenue, by Nutrition Type (2019-2030)
25.4. Market Revenue, by Form (2019-2030)
25.5. Market Revenue, by Patient Type (2019-2030)
25.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Product Type (2019-2030)
26.3. Market Revenue, by Nutrition Type (2019-2030)
26.4. Market Revenue, by Form (2019-2030)
26.5. Market Revenue, by Patient Type (2019-2030)
26.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Product Type (2019-2030)
27.3. Market Revenue, by Nutrition Type (2019-2030)
27.4. Market Revenue, by Form (2019-2030)
27.5. Market Revenue, by Patient Type (2019-2030)
27.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Product Type (2019-2030)
28.3. Market Revenue, by Nutrition Type (2019-2030)
28.4. Market Revenue, by Form (2019-2030)
28.5. Market Revenue, by Patient Type (2019-2030)
28.6. Market Revenue, by Distribution Channel (2019-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Abbott Laboratories
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. B. Braun SE
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. DANONE
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. Nestle S.A.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. Fresenius Kabi AG
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. Reckitt Benckiser Group PLC
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Global Health Products, Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports

Enteral Nutrition Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)